Martha E. Trieschmann

650 total citations
10 papers, 438 citations indexed

About

Martha E. Trieschmann is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martha E. Trieschmann has authored 10 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 5 papers in Psychiatry and Mental health and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martha E. Trieschmann's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Schizophrenia research and treatment (5 papers). Martha E. Trieschmann is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Schizophrenia research and treatment (5 papers). Martha E. Trieschmann collaborates with scholars based in United States. Martha E. Trieschmann's co-authors include Hubert H. Fernandez, Joseph H. Friedman, Michael S. Okun, Richard H. Myers, Margaret C. Lannon, Janet Romrell, James M. Gilchrist and Charles E. Jacobson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Movement Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Martha E. Trieschmann

9 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha E. Trieschmann United States 7 340 166 100 39 34 10 438
Daun Bahr United Kingdom 4 199 0.6× 78 0.5× 107 1.1× 42 1.1× 30 0.9× 7 321
Victor Abler United States 14 252 0.7× 158 1.0× 131 1.3× 51 1.3× 43 1.3× 47 454
Kersi J. Bharucha United States 11 222 0.7× 115 0.7× 52 0.5× 81 2.1× 12 0.4× 13 366
Kathryn A Wyman‐Chick United States 12 240 0.7× 148 0.9× 31 0.3× 35 0.9× 12 0.4× 36 356
Takao Nozaki Japan 10 184 0.5× 28 0.2× 54 0.5× 33 0.8× 31 0.9× 21 320
Govindan Gopinathan United States 11 274 0.8× 43 0.3× 98 1.0× 24 0.6× 25 0.7× 22 344
Jane Newby United Kingdom 5 226 0.7× 134 0.8× 21 0.2× 49 1.3× 64 1.9× 5 322
Bruno Tartaglione Italy 5 149 0.4× 101 0.6× 57 0.6× 41 1.1× 14 0.4× 5 288
Kathrin Marini Austria 10 196 0.6× 49 0.3× 58 0.6× 53 1.4× 47 1.4× 13 326
P. De Domenico Italy 6 188 0.6× 121 0.7× 106 1.1× 57 1.5× 46 1.4× 15 367

Countries citing papers authored by Martha E. Trieschmann

Since Specialization
Citations

This map shows the geographic impact of Martha E. Trieschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Trieschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Trieschmann more than expected).

Fields of papers citing papers by Martha E. Trieschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha E. Trieschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Trieschmann. The network helps show where Martha E. Trieschmann may publish in the future.

Co-authorship network of co-authors of Martha E. Trieschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martha E. Trieschmann. A scholar is included among the top collaborators of Martha E. Trieschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha E. Trieschmann. Martha E. Trieschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Fernandez, Hubert H., Janet Romrell, Martha E. Trieschmann, et al.. (2008). New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine. 3(1). 2 indexed citations
2.
Fernandez, Hubert H., Janet Romrell, Martha E. Trieschmann, et al.. (2008). New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine. SHILAP Revista de lepidopterología. 3. DTI.S650–DTI.S650. 1 indexed citations
3.
Friedman, Joseph H., Martha E. Trieschmann, Richard H. Myers, & Hubert H. Fernandez. (2005). Monozygotic Twins Discordant for Huntington Disease After 7 Years. Archives of Neurology. 62(6). 995–7. 31 indexed citations
4.
Fernandez, Hubert H., Martha E. Trieschmann, & Michael S. Okun. (2004). Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease. Movement Disorders. 20(1). 104–105. 32 indexed citations
5.
Fernandez, Hubert H., Margaret C. Lannon, Martha E. Trieschmann, & Joseph H. Friedman. (2004). Botulinum toxin type B for gait freezing in Parkinson's disease.. PubMed. 10(7). CR282–4. 27 indexed citations
6.
Fernandez, Hubert H., Martha E. Trieschmann, & Joseph H. Friedman. (2004). Aripiprazole for Drug-Induced Psychosis in Parkinson Disease: Preliminary Experience. Clinical Neuropharmacology. 27(1). 4–5. 87 indexed citations
7.
Fernandez, Hubert H., et al.. (2003). Long‐term outcome of quetiapine use for psychosis among parkinsonian patients. Movement Disorders. 18(5). 510–514. 101 indexed citations
8.
Fernandez, Hubert H., Martha E. Trieschmann, & Joseph H. Friedman. (2003). Treatment of Psychosis in Parkinson???s Disease. Drug Safety. 26(9). 643–659. 86 indexed citations
9.
Fernandez, Hubert H., et al.. (2002). Quetiapine for Psychosis in Parkinson's Disease Versus Dementia With Lewy Bodies. The Journal of Clinical Psychiatry. 63(6). 513–515. 71 indexed citations
10.
Trieschmann, Martha E. & James M. Gilchrist. (2002). POEMS syndrome in a patient presenting with chronic inflammatory demyelinating polyneuropathy.. PubMed. 85(8). 252–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026